Meet with... Canaan Partners

Add this event to your calendar:
12/05/2015 12:30 12/05/2015 14:30 America/Los_Angeles Meet with... Canaan Partners StartX , 2627 Hanover Street , Palo Alto , CA 94304 JLABS Bay Area false DD/MM/YYYY

Meet with... Canaan Partners

StartX , 2627 Hanover Street , Palo Alto , CA 94304

May 12, 2015 from 12:30 PM to 14:30 PM (PST)

$10 - $35

JLABS BAY AREA EVENT How are you impacting medicine?
Canaan Partners is a global venture capital firm that invests in entrepreneurs with visionary ideas. With $4.2 billion under management and over 160 exits to date, Canaan has funded some of the world's leading technology companies including LendingClub, Ebates, PrimeSense, and Skybox Imaging as well as healthcare stars like Chimerix, Durata, Labrys Biologics, and Civitas Therapeutics. Canaan recently announced Fund X, a $675 million fund focused on early stage IT and healthcare startups. The fund's healthcare focus includes biopharma, medical devices, and digital health.

Julie Papanek, Principal at Canaan Partners, will be in attendance on May 12th to provide an overview presentation of Canaan's areas of interest and best practices when applying for funding. Julie will be on hand to meet with a handful of applicants one-on-one after the presentation. To be considered for a one-on-one meeting, complete the information required here.

10:30am | Registration and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
12:30-5:00pm | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ended on April 7th.

Canaan Partners Participating Representative:
Julie Papanek | Principal, Canaan Partners read bio»

About Canaan Partners:
Canaan Partners is a global venture capital firm that invests in people with visionary ideas. The kind that not only result in new and valuable technology, but game-changing healthcare startups as well. We were early investors in some of the world's leading technology companies, including PrimeSense, SuccessFactors and LendingClub and healthcare stars like Cerexa, Chimerix and Advanced BioHealing. All of which makes one thing perfectly clear. When people are your priority, good things happen.

Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until May 11th (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ended on April 7th. Your application will be reviewed and you will be notified of acceptance by April 21, 2015. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.

2627 Hanover Street
Palo Alto, California

Canaan Partners Representative's Biography:
Julie Papanek Julie Papanek | Principal, Canaan Partners
If it looks challenging, it's a "maybe." If it's for a good cause, it's a "probably." If it looks really challenging and it's for a good cause, you can clear Julie Papanek's calendar. Julie biked 4000 miles across the country to raise money for Habitat for Humanity, and has competed in triathlons to benefit the Leukemia and Lymphoma Society. It's no secret that Julie takes the same approach when investing. Better startups just aren't enough... she wants better patient outcomes.
Julie brings operational experience from biotechnology and healthIT. Prior to Canaan, Julie worked at Genentech in a variety of positions spanning marketing, development, and business development. This included creating commercial brand plans, forecasting, and recommending modifications to Phase III trials designs for marketed and pipeline oncology products. Recently, she interned at Proteus Digital Health, identifying market opportunities for their digital health platform and generating business development leads. Julie also worked in Bangalore, implementing the pilot electronic medical record system at Narayana Hrudayalaya, one of India's largest multispecialty hospital chains.
Julie holds an MBA from Stanford's Graduate School of Business, where she was the teaching assistant for the Biodesign Innovation course and an officer of the Healthcare Club. Previously, she earned an MPhil from Cambridge University in BioScience Enterprise and a B.S. from Yale University in Molecular Biophysics and Biochemistry.

Julie's Favorite Things: "High adrenaline sports. Observers may yell 'yard sale!' when I ski, and I may spend more time under the water than above it when I kiteboard, but I keep coming back for more."
Connect with Julie: Connect on LinkedIn Connect on Twitter  

About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Thomas McNerney & Partners, NCATS, Poliwogg, and OrbiMed.

JLABS Bay Area

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit or follow @JNJInnovation.

Event contact

Related content